These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35460749)

  • 21. Differential distribution of the MeCP2 splice variants in the postnatal mouse brain.
    Dragich JM; Kim YH; Arnold AP; Schanen NC
    J Comp Neurol; 2007 Apr; 501(4):526-42. PubMed ID: 17278130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome.
    Merritt JK; Collins BE; Erickson KR; Dong H; Neul JL
    Hum Mol Genet; 2020 Aug; 29(15):2461-2470. PubMed ID: 32469049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation and Characterization of a Human Neuronal In Vitro Model for Rett Syndrome Using a Direct Reprogramming Method.
    Huber A; Sarne V; Beribisky AV; Ackerbauer D; Derdak S; Madritsch S; Etzler J; Huck S; Scholze P; Gorgulu I; Christodoulou J; Studenik CR; Neuhaus W; Connor B; Laccone F; Steinkellner H
    Stem Cells Dev; 2024 Mar; 33(5-6):128-142. PubMed ID: 38164119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.
    De Felice C; Della Ragione F; Signorini C; Leoncini S; Pecorelli A; Ciccoli L; Scalabrì F; Marracino F; Madonna M; Belmonte G; Ricceri L; De Filippis B; Laviola G; Valacchi G; Durand T; Galano JM; Oger C; Guy A; Bultel-Poncé V; Guy J; Filosa S; Hayek J; D'Esposito M
    Neurobiol Dis; 2014 Aug; 68(100):66-77. PubMed ID: 24769161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe offtarget effects following intravenous delivery of AAV9-MECP2 in a female mouse model of Rett syndrome.
    Matagne V; Borloz E; Ehinger Y; Saidi L; Villard L; Roux JC
    Neurobiol Dis; 2021 Feb; 149():105235. PubMed ID: 33383186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
    Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
    Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
    Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
    Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treating Rett syndrome: from mouse models to human therapies.
    Vashi N; Justice MJ
    Mamm Genome; 2019 Jun; 30(5-6):90-110. PubMed ID: 30820643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
    Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
    OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes.
    Tsujimura K; Irie K; Nakashima H; Egashira Y; Fukao Y; Fujiwara M; Itoh M; Uesaka M; Imamura T; Nakahata Y; Yamashita Y; Abe T; Takamori S; Nakashima K
    Cell Rep; 2015 Sep; 12(11):1887-901. PubMed ID: 26344767
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rett syndrome: a neurological disorder with metabolic components.
    Kyle SM; Vashi N; Justice MJ
    Open Biol; 2018 Feb; 8(2):. PubMed ID: 29445033
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Separate respiratory phenotypes in methyl-CpG-binding protein 2 (Mecp2) deficient mice.
    Bissonnette JM; Knopp SJ
    Pediatr Res; 2006 Apr; 59(4 Pt 1):513-8. PubMed ID: 16549521
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
    Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
    Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of MeCP2 in the rat models regression, impaired sociability and transcriptional deficits of Rett syndrome.
    Veeraragavan S; Wan YW; Connolly DR; Hamilton SM; Ward CS; Soriano S; Pitcher MR; McGraw CM; Huang SG; Green JR; Yuva LA; Liang AJ; Neul JL; Yasui DH; LaSalle JM; Liu Z; Paylor R; Samaco RC
    Hum Mol Genet; 2016 Aug; 25(15):3284-3302. PubMed ID: 27365498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes.
    Kerr B; Soto C J; Saez M; Abrams A; Walz K; Young JI
    Eur J Hum Genet; 2012 Jan; 20(1):69-76. PubMed ID: 21829232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disruption of MeCP2 attenuates circadian rhythm in CRISPR/Cas9-based Rett syndrome model mouse.
    Tsuchiya Y; Minami Y; Umemura Y; Watanabe H; Ono D; Nakamura W; Takahashi T; Honma S; Kondoh G; Matsuishi T; Yagita K
    Genes Cells; 2015 Dec; 20(12):992-1005. PubMed ID: 26456390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.